Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$716,843
+$342,243 QoQ
Shares Held
29,247
+36.6% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 151 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. BIOA ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
68,214,436 | $1,083,245,243 | |
| 2 | ALKS |
Alkermes plc.
|
6,737,328 | $353,035,986 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,903,354 | $211,158,092 | |
| 4 | LQDA |
Liquidia Corp
|
1,940,364 | $154,705,221 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
243,444 | $131,905,262 | |
| 6 | PRGO |
PERRIGO Co plc
|
8,700,421 | $90,397,373 | |
| 7 | ZTS |
Zoetis Inc.
|
1,139,097 | $81,855,510 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,679,152 | $56,889,668 |
All Filings in BIOA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $716,843 | 29,247 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $374,600 | 21,418 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $195,909 | 14,808 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $69,919 | 11,891 | Shares | Defined | 2025-11-14 | |
| 2024-09-30 | $9,356,609 | 449,837 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||